SCHEMBL7299287

SCHEMBL7299287

CCOC(=O)N(CCCCCl)c1cc(OC)ccc1C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PLA2G2A P14555 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAOB P27338 2/20 0.36
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
GLA P06280 1/20 0.36
CA3 P07451 1/20 0.36
GAA P10253 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298470 0.91 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDSMN1; SMN2CYP1A2
SCHEMBL7298114 0.84 SMN1; SMN2 (0.41) ALDH1A1KDM4EHPGDSMN1; SMN2TDP1
SCHEMBL7302767 0.83 SMN1; SMN2 (0.45) ALDH1A1KDM4EHPGDSMN1; SMN2CYP1A2
SCHEMBL7302145 0.77 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDSMN1; SMN2TDP1
SCHEMBL7302756 0.77 SMN1; SMN2 (0.43) ALDH1A1KDM4EHPGDSMN1; SMN2CYP1A2
SCHEMBL7306783 0.76 HTR1A (0.46) ALDH1A1KDM4EGAAMAPT
SCHEMBL7309288 0.76 TSHR (0.40) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C9
SCHEMBL7302910 0.75 TP53 (0.44) ALDH1A1KDM4EHPGDSMN1; SMN2CYP1A2
SCHEMBL7303328 0.75 NR4A2 (0.39) ALDH1A1KDM4EHPGDSMN1; SMN2CYP1A2
SCHEMBL9432839 0.74 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed